My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Soligenix, Inc. - Common Stock (NQ:SNGX)

1.080 -0.040 (-3.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year ↗

January 14, 2025

Soligenix's IIS study on HyBryte for cutaneous T-cell lymphoma shows 70% success and strong safety profile, with Phase 3 enrollment ongoing.

Via Benzinga

Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL

December 17, 2024

Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL

Via News Direct

EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer ↗

December 16, 2024

Soligenix opens enrollment for the Phase 3 FLASH2 study of HyBryte in early-stage CTCL, aiming to confirm extended treatment efficacy over 18 weeks.

Via Benzinga

Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs

November 27, 2024

Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs

Via News Direct

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

November 27, 2024

Via ACCESSWIRE

Soligenix Announces Participation at the Spartan Capital Investor Conference

October 29, 2024

Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement

Via TheNewswire.com

5 Investors Betting Big on Soligenix (SNGX) Stock ↗

July 09, 2024

SNGX stock is elevating higher after Soligenix released positive results from its HyBryte study. Here are the company's top investors.

Via InvestorPlace

Soligenix to Present at November 21st Virtual Investor Summit Microcap Event

November 15, 2024

Via ACCESSWIRE

Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels ↗

November 14, 2024

Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025. Trial includes efficacy assessments.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 01, 2024

Via Benzinga

Soligenix Announces Participation at the Spartan Capital Investor Conference

October 29, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 03, 2024

Via Benzinga

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

October 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 02, 2024

Via Benzinga

Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

September 20, 2024

Via ACCESSWIRE

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

August 16, 2024

Via ACCESSWIRE

7 Top Stocks Under $10: July 2024 Edition ↗

July 31, 2024

There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.

Via InvestorPlace

MarketBeat Week in Review – 7/8 - 7/12

July 13, 2024

Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week

Via MarketBeat

Topics Economy Stocks

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 10, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 10, 2024

Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!

Via InvestorPlace

Uncover Why This Pharma Stock Jumped 400% on Study Update

July 10, 2024

Shares of Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, surged almost 400% today after announcing positive data.

Via MarketBeat

Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket ↗

July 10, 2024

Via Benzinga

S&P 500 Edges Higher; Indivior Shares Plummet ↗

July 09, 2024

Via Benzinga

Topics Stocks

Stocks Mixed Following Powell Testimony ↗

July 09, 2024

The S&P 500 Index and Nasdaq Composite Index are once again extending their record highs, both modestly higher midday.

Via Talk Markets

Topics Stocks

Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 09, 2024

Via Benzinga

Crude Oil Down 1%; Soligenix Shares Surge ↗

July 09, 2024

Via Benzinga

Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why ↗

July 09, 2024

Soligenix shares surged on heavy volume, following an interim update on the extended Hybryte treatment study.

Via Benzinga

Why Is uniQure (QURE) Stock Up 51% Today? ↗

July 09, 2024

UniQure stock is up on Tuesday as QURE investors react to positive clinical trial data for its Huntington’s Disease treatment candidate.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.